Effect of CYP3A4*1G/3A5*3 gene polymorphism on concentration/dose ratios of diltiazem in kidney transplant patients
	    		
		   		
	    	
    	
    	
   		
        
        	
        		- VernacularTitle:CYP 3A4*1G和3A5*3基因多态性对肾移植患者地尔硫浓度/剂量比的影响
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		YI-Xin
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Jiang-Lin WANG
			        		
			        		;
		        		
		        		
		        		
			        		Ya-Nan ZHOU
			        		
			        		;
		        		
		        		
		        		
			        		Qing-Jie CHEN
			        		
			        		;
		        		
		        		
		        		
			        		Ke CHENG
			        		
			        		;
		        		
		        		
		        		
			        		Ying-Zi MING
			        		
			        		;
		        		
		        		
		        		
			        		Ying MA
			        		
			        		;
		        		
		        		
		        		
			        		Xiao-Cong ZUO
			        		
			        		
		        		
		        		
		        		
		        		
		        			
			        		
			        		Author Information
			        		
		        		
		        		
			        		
			        		
			        			1. 湘潭市中心医院 科教科
			        		
		        		
	        		
        		 
        	
        	
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		diltiazem;
			        		
			        		
			        		
				        		cytochrome P450 3A4*1G;
			        		
			        		
			        		
				        		cytochrome P450 3A5*3;
			        		
			        		
			        		
				        		gene polymorphisms;
			        		
			        		
			        		
				        		kidney transplant
			        		
			        		
	        			
        			
        		
 
        	
            
            
            	- From:
	            		
	            			The Chinese Journal of Clinical Pharmacology
	            		
	            		 2014;(8):667-670
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	Objective To investigate the impact of the CYP3A4*1G and CYP3 A5*3 polymorphisms on the concentration/dose ratios of dilti-azem in kidney transplant patients.Methods Forty -seven cases of kidney transplant recipients were recruited.CYP3A4 and CYP3A5 geno-types were determined by polymerase chain reaction -restriction fragment length polymorphism.Plasma trough concentration of diltiazem was meas-ured by HPLC.The effects of CYP3A4*1G and CYP3A5*3 gene poly-morphisms on the concentration/dose ratios of diltiazem were evaluated and compared.Results There were fourteen cases of CYP3A4*1*1 (29.79%) homozygous genotype , twenty six cases of CYP3A4*1*1G (55.32%) heterozygous genotype , and seven cases of CYP3A4*1G*1G (14.89%) homozygous genotype.Allele frequencies of CYP3A4*1 and *1G were 57.45%and 42.55%, respectively.There were six ca-ses with CYP3A5*1*1 (12.77%), twenty one cases with CYP3A5*1*3(44.68%), and twenty cases with CYP3A5*3*3(42.55%).Allele frequencies of CYP3A5*1 and *3 were 35.11%and 64.89%, respectively.CYP3A4*1G gene polymorphisms were significantly related to the concentration /dose of diltiazem in kidney transplant patients.The diltiazem blood trough concentration/dose in CYP3A4*1*1 recipients was 1.52 times higher than that in patients with CYP 3A4*1G allelic genes.There was significant difference in diltiazem blood trough concen-tration/dose ratios between recipients with CYP3A4*1*1 genotypes and CYP3A4*1G carriers(P<0.05).CYP3A5*3 gene polymorphisms had slight impacts on diltiazem blood trough concentration /dose ratios but no difference was found among the CYP3A5 genotypes.Conclusion The CYP3A4*1G gene polymorphism is closely related to the blood con-centration/dose ratios of diltiazem in kidney transplant patients.